Neuroene selected by CED to present on the main stage at the CED Life Science Conference in Raleigh this February 26-27
EurekAlert: Neuroene Therapeutics awarded $1.5 million to develop anti-seizure compound for epilepsy
Selection of Neuroene Therapeutics as an Early-Stage presenting company at the SEBIO Investor Forum in Atlanta
For the "Entrepreneurship: turning your innovative ideas into a marketable product" workshop.
Compositions and methods for treating neurological diseases or injury. Issued on January 9, 2018
Notice of Allowance received from U.S. Patent and Trademark Office for "Compositions And Methods For Treating Neurological Diseases Or Injury"